Literature DB >> 17659675

Frequent loss of heterozygosity at 8p22 chromosomal region in diffuse type of gastric cancer.

Hedayat Allah Hosseini1, Ali Ahani, Hamid Galehdari, Ali Mohammad Froughmand, Masoud Hosseini, Abdolrahim Masjedizadeh, Mohammad Reza Zali.   

Abstract

AIM: To study the loss of heterozygosity (LOH) at 8p21-23 locus in diffuse gastric cancer.
METHODS: To evaluate the involvement of this region in gastric cancer, we used eight microsatellite markers covering two Mb of mentioned region, to perform a high-resolution analysis of allele loss in 42 cases of late diffuse gastric adenocarcinoma.
RESULTS: Six of these STS makers: D8S1149, D8S1645, D8S1643, D8S1508, D8S1591, and D8S1145 showed 36%, 28%, 37%, 41%, 44% and 53% LOH, respectively.
CONCLUSION: A critical region of loss, close to the NAT2 locus and relatively far from FEZ1 gene currently postulated as tumor suppressor gene in this region.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17659675      PMCID: PMC4172716          DOI: 10.3748/wjg.v13.i24.3354

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  42 in total

Review 1.  The difference in gastric cancer between Japan, USA and Europe: what are the facts? what are the suggestions?

Authors:  P A Davis; T Sano
Journal:  Crit Rev Oncol Hematol       Date:  2001-10       Impact factor: 6.312

2.  Localization of tumor suppressor gene associated with distant metastasis of urinary bladder cancer to a 1-Mb interval on 8p22.

Authors:  K Ohgaki; A Iida; O Ogawa; Y Kubota; M Akimoto; M Emi
Journal:  Genes Chromosomes Cancer       Date:  1999-05       Impact factor: 5.006

3.  Localization of N-acetyltransferases NAT1 and NAT2 in human tissues.

Authors:  K F Windmill; A Gaedigk; P M Hall; H Samaratunga; D M Grant; M E McManus
Journal:  Toxicol Sci       Date:  2000-03       Impact factor: 4.849

4.  Fez1/lzts1 alterations in gastric carcinoma.

Authors:  A Vecchione; H Ishii; Y H Shiao; F Trapasso; M Rugge; J F Tamburrino; Y Murakumo; H Alder; C M Croce; R Baffa
Journal:  Clin Cancer Res       Date:  2001-06       Impact factor: 12.531

5.  The FEZ1 gene at chromosome 8p22 encodes a leucine-zipper protein, and its expression is altered in multiple human tumors.

Authors:  H Ishii; R Baffa; S I Numata; Y Murakumo; S Rattan; H Inoue; M Mori; V Fidanza; H Alder; C M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

6.  Identification of a new target region by loss of heterozygosity at 5p15.33 in sporadic gastric carcinomas: genotype and phenotype related.

Authors:  Yun Lu; Yingyan Yu; Zhenggang Zhu; Heng Xu; Jun Ji; Lei Bu; Bingya Liu; Haisong Jiang; Yanzhen Lin; Xiangyin Kong; Landian Hu
Journal:  Cancer Lett       Date:  2005-01-26       Impact factor: 8.679

7.  Genetic variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2) and risk of non-Hodgkin lymphoma.

Authors:  Lindsay M Morton; Maryjean Schenk; David W Hein; Scott Davis; Shelia Hoar Zahm; Wendy Cozen; James R Cerhan; Patricia Hartge; Robert Welch; Stephen J Chanock; Nathaniel Rothman; Sophia S Wang
Journal:  Pharmacogenet Genomics       Date:  2006-08       Impact factor: 2.089

8.  Mapping of a candidate colorectal cancer tumor-suppressor gene to a 900-kilobase region on the short arm of chromosome 8.

Authors:  James M Flanagan; Sue Healey; Joanne Young; Vicki Whitehall; Deborah A Trott; Robert F Newbold; Georgia Chenevix-Trench
Journal:  Genes Chromosomes Cancer       Date:  2004-07       Impact factor: 5.006

9.  The use of cell fusion to analyse factors involved in tumour cell metastasis.

Authors:  I A Ramshaw; S Carlsen; H C Wang; P Badenoch-Jones
Journal:  Int J Cancer       Date:  1983-10-15       Impact factor: 7.396

Review 10.  Molecular genetics and function of NAT1 and NAT2: role in aromatic amine metabolism and carcinogenesis.

Authors:  David W Hein
Journal:  Mutat Res       Date:  2002-09-30       Impact factor: 2.433

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.